Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0938-2026

HemosIL SynthAFax. Partial Thromboplastin Time Tests. Recall

HemosIL SynthAFax. Partial Thromboplastin Time Tests.

FDA recall Class III

Ongoing

FDA lists this Class III recall for HemosIL SynthAFax. Partial Thromboplastin Time Tests.. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0938-2026
Recall classification
Class III
Enforcement status
Ongoing
Initiation date
Nov 18, 2025
FDA report date
Dec 24, 2025
Quantity in commerce
4,506 units
Distribution
See key details
FDA cause
Process control

What is being recalled?

HemosIL SynthAFax. Partial Thromboplastin Time Tests.

Affected model & UDI checker

Search the exact identifiers published for Z-0938-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedHemosIL SynthAFax. Partial Thromboplastin Time Tests.Check source notice08426950087649
FDA code information

Part No. 0020007400; UDI: 08426950087649; Lot No. (Exp. Date) N0542231(2026-06-30), N0250088(2027-04-30, N0452249 (2027-06-30).

View the original FDA recall notice

Why was this product recalled?

Recalled lots were manufactured with double the amount of preservative concentration.

What actions did Instrumentation Laboratory take?

An URGENT MEDICAL DEVICE RECALL notification, dated 11/18/25, was sent to consignees. Consignees are to contact Client Services at 1-800-955-9525 to arrange conversion to replacement lot N0956748, and in the meantime continue use of affected lots with the QC lot reassignments provided and run QC per labeled instructions for use. Once the replacement lot is received, consignees are to complete the cross-over study per laboratory procedures and immediately destroy affected devices, documenting destruction on the provided Mandatory Urgent Medical Device Recall Tracking Form which should be returned to WERFEN by fax at 781-861-4207 or by email to ra-usa.na@werfen.com. All laboratory staff are to be notified of this recall and a copy of the notice posted near IL Coagulation Systems. Consignees with any questions are to contact Client Services at 1-800-955-9525.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology